Next Article in Journal
The Central Conserved Peptides of Respiratory Syncytial Virus G Protein Enhance the Immune Response to the RSV F Protein in an Adenovirus Vector Vaccine Candidate
Next Article in Special Issue
Applying a Participatory Action Research Approach to Engage an Australian Culturally and Linguistically Diverse Community around Human Papillomavirus Vaccination: Lessons Learned
Previous Article in Journal
The Development of a Multivalent Capripoxvirus-Vectored Vaccine Candidate to Protect against Sheeppox, Goatpox, Peste des Petits Ruminants, and Rift Valley Fever
Previous Article in Special Issue
Stakeholders’ Perceptions on the Implementation of the HPV Vaccine School-Entry Requirement in Puerto Rico during the COVID-19 Pandemic
 
 
Article

Article Versions Notes

Vaccines 2024, 12(7), 806; https://doi.org/10.3390/vaccines12070806
Action Date Notes Link
article xml file uploaded 20 July 2024 10:39 CEST Original file -
article xml uploaded. 20 July 2024 10:39 CEST Update https://www.mdpi.com/2076-393X/12/7/806/xml
article pdf uploaded. 20 July 2024 10:39 CEST Version of Record https://www.mdpi.com/2076-393X/12/7/806/pdf
article html file updated 20 July 2024 10:40 CEST Original file https://www.mdpi.com/2076-393X/12/7/806/html
Back to TopTop